Primis Financial has spent the past three years converting a loss-making, branch-heavy community bank into a platform that pairs a stable core deposit franchise with three higher-returning growth lines. The turnaround swung the company from a net loss in 2024 to strong net income in 2025, built on a large sale-leaseback gain, substantial gains on the Panacea Financial Holdings investment, and a genuine step-up in net interest income as the Fed easing cycle lowered the bank's cost of funds. The second quarter of 2026 confirmed the trajectory with solid net income and a net interest margin up nearly 60 basis points year over year. Total assets were up 8% from the prior year-end. The stock trades at roughly $16 per share, a price that reflects the complexity of the new model rather than fundamental weakness. The central question for shareholders is whether the mortgage warehouse and Panacea divisions can keep scaling without dragging down the capital ratios or the deposit base that funds them.
The balance sheet tells a story of deliberate reallocation. FHLB advances jumped from a small balance at the start of the year to $300 million by mid-2026, showing the bank is actively deploying liquidity into lending. The loan-to-deposit ratio rose to 100.6% from 96.7% in one half, a sign of aggressive loan growth. Nonperforming assets fell 58 basis points to 1.45% of assets, driven in part by one large commercial relationship refinancing elsewhere. The company carries a cushion above the well-capitalized threshold on total risk-based capital, enough headroom for the growth ambitions but not so much that a single credit event would force a recapitalization.
Primis Financial Corp. is the bank holding company for Primis Bank, a Virginia state-chartered bank that opened in 2005 and is headquartered in McLean, Virginia, just outside Washington, D.C. The bank operates 24 full-service branches across Virginia and Maryland, with an administrative office in Glen Allen and an operations center in Atlee. It is an accelerated filer on the Nasdaq Global Market. As of year-end 2025, the company had $4.0 billion in total assets. Loans held for investment stood at $3.3 billion. Deposits were $3.4 billion. Stockholders' equity was $423 million. The company employs 593 people, nearly all full-time, and is led by Chief Executive Officer Dennis J. Zember, Jr.
The strategic architecture has four pillars, each targeting a different return profile. The core community bank maintains the branch network and the relationship deposit base. Deposits per branch in the core markets grew substantially over the past four years. Panacea Financial, a healthcare-focused lending brand, targets medical, dental, and veterinary practices nationwide. Loan balances in the division ended 2025 at $544 million. Deposits in the division reached $128 million. Primis Mortgage Company is a residential mortgage lender acquired from SeaTrust Mortgage. It sold over $1 billion of production in 2025. The bank scaled up Mortgage Warehouse Lending after hiring a seasoned team. The division had $318 million in outstanding balances at year-end 2025. Approved lines in the warehouse program stood at $1.2 billion.
Funding all three growth lines is the digital deposit platform. The balance ended 2025 at roughly $1.0 billion. It held a similar level by mid-2026. The cost of deposits on the platform was 3.79%. Roughly three-quarters of digital deposit customers had been with the bank for at least three years, a tenure figure that tells investors the platform is not a hot-money book that flees at the first sign of a yield improvement elsewhere. The company has zero brokered deposits. The core bank's deposit cost was 1.60% in the second quarter of 2026, down from a year earlier. That spread underwrites the whole growth strategy.
The Panacea Financial Holdings deconsolidation in March 2025 is the single most important structural event in the company's recent history. Three primary executives of PFH resigned from their management roles at the bank's Panacea division, and Primis and PFH amended their partnership agreement to give PFH more control over the type and amount of lending it performs through the bank. Under variable interest entity accounting, Primis determined it was no longer the primary beneficiary and deconsolidated PFH, booking a $25 million gain on the retained 19% common share stake. In June 2025, the bank sold a portion of those shares for $22 million in proceeds. An additional $7 million gain followed from the sale and fair value adjustments. What this means for shareholders is that the bank has traded a variable, hard-to-model equity investment in a healthcare lending brand for a cleaner, more transparent relationship: the bank originates loans through its own Panacea division, retains some and sells others, and collects origination and servicing fees. The $32 million of PFH gains in 2025 is not a recurring revenue stream, and excluding it, the underlying earnings power of the company is meaningfully lower than the headline net income suggests.
The core competitive advantage of Primis is the digital deposit platform. The bank launched the platform in 2022, and it has grown to $1.0 billion in deposits. The average balance per customer is $48,000. The platform funds the mortgage warehouse, the Panacea division, and Primis Mortgage Company without forcing the core community bank to chase expensive deposits in a competitive market. That separation is the architectural moat: the growth businesses draw on a shared deposit pool that is cheaper than wholesale funding but not as expensive as the rate-sensitive digital book. The digital platform's 3.79% cost of deposits is well below what a mortgage warehouse would pay to fund through unsecured borrowings, and the 74% customer tenure at three years or longer suggests the deposits are sticky.
The V1BE service, launched in 2021, is a bank delivery app that brings in-branch services to the customer: cash delivery and withdrawals, check deposits, replacement debit cards, and cashier checks. It was piloted in Richmond and now covers most of the footprint, including the greater Washington, D.C. region. Management has been working to make V1BE licensable to other banks, with the first external customer expected in 2026. If that materializes, V1BE becomes a fee income source that scales without the bank having to grow its own branch network.
In mortgage warehouse lending, the underwriting and monitoring run through the bank's Warehouse Loan System, which checks program compliance automatically. The loans are predominantly secured by marketable residential mortgages underwritten to agency guidelines, typically funded for 10 to 15 days before the underlying loan is sold to an upstream investor. That short tenor and the agency-guarantee quality of the collateral make the warehouse book one of the lower-risk loan categories on the balance sheet, provided the origination volume keeps the lines turning. The warehouse balance grew 71% in the first half of 2026, more than doubling from the prior year-end level. The bank funded an average of 12% of outstanding warehouse loans with associated customer noninterest bearing deposit balances, a structural advantage that lowers the effective funding cost of the book.
Primis Mortgage Company operates in the majority of the United States and primarily sells its production to the secondary market for fee income. Funded production was $1.2 billion, a substantial increase from the prior year. First half 2026 production was $788 million, a strong year over year gain. Pre-tax earnings at PMC were $2 million. The jump from the prior year period is large. The mortgage banking income line on the income statement, which includes gain-on-sale revenue and interest rate lock commitment fair value changes, was $11.4 million in the second quarter. The six-month total was $22.1 million. The Panacea division offers practice loans for medical, dental, and veterinary businesses, covering acquisition, start-up, expansion, real estate purchase, refinance, leasehold, equipment, and buy-in financing. It also offers unsecured consumer products including student loan refinancing and pro re nata loans for in-training physicians, dentists, and veterinarians. The division's loan balances grew 13% in the first half of 2026. The healthcare vertical is structurally defensive: physician practices have stable cash flows, low default rates historically, and a high barrier to entry for new competitors. Associated deposits grew in line with the loan book. The division can distribute production across the country while retaining servicing relationships with the practices that originate the loans.
The 2025 income statement is the clearest example of why headline earnings at Primis can be misleading. Net income of $61 million included a $51 million sale-leaseback gain. It also included $32 million of PFH investment gains. A $15 million loss on the sale of investment securities in the portfolio restructuring offset part of those gains. Stripping out those one-time items, the core earnings were closer to $17 million. That is roughly $0.68 per share. That number is consistent with the first half run rate. The 2024 net loss reflected a large provision and charge-off event on the Consumer Program portfolio. A substantial provision for credit losses compounded the problem. The Consumer Program, a third-party originated unsecured consumer loan portfolio, was wound down after the bank ceased originating new loans in the following January.
Net interest income is the engine. It rose to an annualized pace of roughly $132 million in the first half of 2026. That is up about $14 million year over year for the six-month period. The driver is a widening net interest margin of 3.45% in the second quarter of 2026. That is up nearly 60 basis points from a year earlier. Deposit costs fell as the Fed easing cycle took hold, and the mix shift toward more noninterest bearing deposits from the mortgage warehouse operating accounts added further spread. The core bank's deposit cost of 1.60% is the anchor. The digital platform at 3.79% is the growth engine. The two together produce a blended cost that is well below what a pure warehouse lender would pay.
Noninterest income in the first half of 2026 was $35.6 million, down from a year earlier. The decline is entirely explained by the absence of the PFH gains in the comparison period. Mortgage banking income was $22.1 million, up from a year earlier. A one-time gain on the liquidation of an insurance agency investment also flattered the period. Excluding those items, noninterest income was up on the strength of the mortgage lines. Noninterest expense of $72.0 million in the first half of 2026 reflects the investment phase. Personnel costs rose with PMC and the mortgage warehouse teams. The sale-leaseback converted 18 branch properties into a long-term triple net lease. Base rent is $5 million per year. The data processing contract executed in the second half of 2025 is already showing savings.
Capital ratios remain comfortable but are trending down as the balance sheet grows. The holding company CET1 was 9.33% at mid-2026. That is down 3 basis points from year-end. Total risk-based capital was 12.15%. The bank's own CET1 was 10.63%, above the well-capitalized threshold. The FHLB advances line of $300 million is the most visible sign that management is leveraging the balance sheet to fund loan growth faster than deposits are growing. That is a deliberate choice: the bank is trading a small amount of capital ratio headroom for a large amount of net interest income growth. The efficiency ratio in the first half was roughly 62%, a level that leaves room for expense growth to be absorbed by the revenue lines if the warehouse and mortgage businesses keep scaling.
The mortgage warehouse is the highest-conviction growth variable. The balance went from $318 million to $544 million in six months. That is a 71% increase, against a backdrop of $1.2 billion in approved lines. The bank hired a proven team in late 2024 and has been scaling the book since. The risk is that warehouse lending is a volume business: if origination volumes at the customer mortgage companies slow, the balance shrinks quickly and the net interest income contribution falls with it. The short tenor of the loans, typically 10 to 15 days, means the book turns over rapidly, so a slowdown in the housing market or in mortgage refinancing activity would show up in the warehouse balance within a quarter. The 12% noninterest bearing deposit offset is a structural cushion, but it only covers a fraction of the funding need.
The Panacea division is the longer-term variable. Loan balances of $617 million with $169 million in deposits represent a growing, sticky, relationship-based franchise. The healthcare vertical is less cyclical than commercial real estate, and the division's 32% deposit growth rate suggests the bank is successfully cross-selling the deposit products to the lending relationships. The sale of $54 million of Panacea loans to another financial institution in 2025 shows the division can both retain loans for spread income and sell them for capital relief. The bank booked over $1 million in gains on the transaction. The deconsolidation of PFH means the bank no longer consolidates the equity value of the brand, but it also means the bank has a cleaner, more transparent fee income stream from the division's origination and servicing activities.
The digital deposit platform is the funding variable. At $1.0 billion and growing, with 74% of customers at three years or longer, the platform is the most defensible asset on the balance sheet. The risk is that the 3.79% cost of deposits, while competitive, is still more than twice the core bank's deposit cost. If the bank needs to grow the platform faster to fund the warehouse and Panacea lines, the blended deposit cost rises, compressing the net interest margin. The V1BE licensing opportunity, if the first external bank customer comes online in 2026, adds a new revenue line that does not require additional deposit funding.
The execution risk is concentration. Three of the four growth lines are being scaled simultaneously, and the expense base is growing with them. The 62% efficiency ratio is manageable, but it deteriorates if any one of the three lines stalls while the expense headcount stays in place. The sale-leaseback adds a fixed lease obligation of $5 million per year, escalating 2%, which creates a minimum expense floor that the revenue lines have to clear. The material weakness in internal controls over financial reporting, disclosed in the annual filing, is a governance overhang that investors should watch, particularly as the balance sheet becomes more complex with the related party transactions with PFH and the growth in the warehouse book.
The most immediate credit risk is in the commercial real estate portfolio. Investor commercial real estate loans were 23% of total loans at mid-2026. The annual filing notes that 37% of the loan portfolio was secured by commercial real estate, including multifamily residential and farmland loans, at year-end 2025. A downturn in office or retail property values in the mid-Atlantic market would hit the core bank's balance sheet directly. The allowance for credit losses is 1.33% of total loans, down from 1.40% at year-end, which gives the bank some cushion but not much. A material commercial real estate loss event would require a provision that could wipe out several quarters of net income.
The Consumer Program run-off is a residual risk that is nearly but not fully resolved. The portfolio stood at $90 million at year-end 2025. The bank expects the promotional loan periods to end through the second quarter of 2026. The 2024 charge-off event was severe, and the bank's credit loss experience on that portfolio was worse than the reserve assumptions. The portfolio is in run-off, so the balance is declining, but the final losses on the remaining balance could still surprise. The allowance for the Consumer Program is a meaningful part of the total $46 million ACL, and a write-up in expected losses would reduce net income without any change in loan production.
The mortgage warehouse is exposed to a two-sided risk. On the funding side, the $300 million FHLB advance line is the primary source of warehouse funding, and a tightening in FHLB availability or a rise in advance rates would increase the cost of the book. On the collateral side, the warehouse loans are secured by residential mortgages that are typically sold to agency buyers within two weeks. A sharp decline in housing prices or a freeze in the agency buying market would extend the warehouse tenor and increase the bank's exposure to the underlying collateral. The 12% noninterest bearing deposit offset mitigates some of this, but it is not a complete hedge.
The capital ratio trajectory is a structural risk. CET1 at 9.33% and total risk-based capital at 12.15% are above the well-capitalized thresholds. The 25 basis point decline in total risk-based capital in one half, driven by balance sheet growth, is a signal. If the warehouse and Panacea lines continue to grow at their current pace, the capital ratios compress further unless the bank issues new equity or slows its growth. The company has an S-3 registration statement on file, which gives it the option to raise capital, but the dilution cost of a follow-on offering at the current share price is significant. The 2.48% dividend yield is a real claim on earnings, and cutting it is a negative signal to the investor base.
The stock trades at $15.96 per share, or a market capitalization of approximately $396 million. Book value per share is $17.54, giving a price to book ratio of 0.91. The trailing twelve month price to earnings ratio is 7.5. That multiple is inflated by the one-time gains last year. On a normalized basis, excluding the sale-leaseback gain, the PFH gains, and the securities restructuring loss, the core earnings were closer to $17 million. That puts the stock at roughly 23 times normalized earnings. The first half run rate of $16.7 million in net income is consistent with that normalized figure. The headline multiples therefore overstate the earning power of the franchise, and any valuation case has to start from the normalized number rather than the reported one.
The bear case values the bank at 0.75 times book value, or about $13 per share. The mechanism is a slowdown in mortgage origination volumes that shrinks the warehouse book and the mortgage banking income line, combined with a commercial real estate loss event that forces a provision of $10 million to $15 million. In that scenario, the net interest margin compresses as the bank pulls back on FHLB funding, and the capital ratios fall below the current levels. The dividend yield rises as the share price falls, but the sustainability of the quarterly dividend is questioned.
The base case holds the share price near the current level, around $16, as the warehouse and Panacea lines continue to scale. The net interest margin stabilizes in the mid-single digit range, the efficiency ratio improves as the expense base matures, and the capital ratios hold in the low-to-mid 9% range for CET1. Normalized earnings of $20 million to $22 million for the full year support a price to book ratio below one. The per-share equivalent is about $0.80 to $0.88, which prices the bank for steady growth rather than acceleration. The scenario is internally consistent: each moving part supports the others without any single assumption doing the heavy lifting.
The bull case values the stock at 1.10 times book value, or about $19 per share. The mechanism is a faster-than-expected scaling of the mortgage warehouse, with the balance nearly doubling, and the V1BE licensing producing a meaningful fee income contribution. The Panacea division continues to grow deposits at a double-digit rate. In that scenario, normalized earnings reach $25 million to $28 million. That is $1.00 to $1.12 per share. The multiple expands as investors recognize that the growth lines are producing durable, above-average risk-adjusted returns. The dividend yield falls below 2%, still respectable for a bank with this growth profile. The base case and the bull case both rest on the same assumption: the growth lines keep scaling without forcing a credit event or a capital raise that would dilute existing holders.
Primis Financial is not a typical community bank at its current valuation. The 0.91 price to book and the 7.5 trailing multiple reflect a market that is pricing the one-time gains into the earnings base and discounting the execution risk of scaling three growth lines simultaneously. The honest read is that the core earnings power of the company is around $0.68 to $0.75 per share. That is a modest return on equity of roughly 12% to 14%. It is better than the 10% to 11% return on tangible equity that a mature community bank without the growth lines would produce.
The argument for the stock is that the growth lines are real, the funding infrastructure is in place, and the capital ratios, while declining, still have room. The digital deposit platform at $1.0 billion with 74% customer tenure at three years or longer is a genuine moat that most community banks of this size do not have. The mortgage warehouse, funded at 12% by customer operating deposits, has a structural funding advantage that the bank did not have before the team was hired in late 2024. The Panacea division holds $617 million in loans and $169 million in deposits. The deposits are growing at a double-digit rate. The division is a defensible niche in a vertical with low default rates and high customer loyalty.
The argument against is that the headline earnings are not sustainable at the 2025 level, the capital ratios are trending down in the direction that matters, and the bank is carrying a material weakness in internal controls while it scales a more complex balance sheet. The $5 million per year in lease expense from the sale-leaseback is a fixed cost that the revenue lines have to clear. The 62% efficiency ratio leaves less room for a credit event than a 50% efficiency ratio would. The consumer program run-off is not yet complete, and the final loss experience on that portfolio is still unknown.
The judgment is that the stock is fairly valued at the current price, with a modest skew to the downside in the next four quarters as the one-time gains fade from the trailing twelve month window and the market re-prices the stock on normalized earnings. The 0.91 price to book is not a value trap if the growth lines deliver, but it is not a deep value either. The 2.48% dividend is a floor of support, and the S-3 on file is a cap on the downside if the capital ratios compress too far. For an investor who believes the mortgage warehouse and Panacea division can scale to the levels implied by the current growth trajectory, the stock is attractive at the current price. For an investor who is skeptical that three simultaneous growth initiatives can be executed without a credit event or a capital raise, the stock is overpriced at the current multiple. The weight of evidence from the first half of 2026 tilts the assessment toward the former camp. Net interest margin is up 59 basis points, and the warehouse balance is up 71%. Nonperforming assets are down 58 basis points. The margin of safety is thin, but the direction of travel is right.